1. Hoshimoto K, Ohta Y, Ohkura T, Inaba N.
Changes in plasma soluble CD26 and CD30 during pregnancy : markers of Th1/Th2 balance?
Gynecol Obstet Invest 50(4) : 260-263, 2000.
2. Hoshimoto K, Hayashi M, Ohkura T.
Plasma levels of soluble Fas during normal pregnancy.
Gynecol Obstet Invest.2001 Feb;51(2):96-98.
3. Hoshimoto K, Hayashi M, Ohkura T.
CD26 and CD30 expression on the surface of lymphocyte during normal pregnancy.
Gynecol Obstet Invest. 2001;52(1):9-12.
4. Hoshimoto K, Mitsuya K, Ohkura T .
Osteochondroma of the pubic symphysis associated with sexual disturbance.
Gynecol Obstet Invest 50(1) : 70-72, 2000.
5. Hoshimoto K, Hayashi M, Ohkura T.
Regulation of dosage of conjugated equine estrogen is useful for add- back therapy.
J Med 31:167-175, 2000.
6. Hoshimoto K, Ohkura T.
Vascular endothelial growth factor in human milk.
Br J Biomed Sci 57(3) : 215-217, 2000.
7.Hoshimoto K, Hayashi M, Ohkura T.
Mature adrenomedullin concentrations in plasma during pregnancy.
J Matern Fetal neonatal med. 2002 Feb; 11(2) 126-9
8. Hoshimoto K, Komine F, Hayashi M, Ohkura T.
Plasma soluble Fas changes during early pregnancy and miscarriage.
Clin Chim Acta 2002 Sep 323 (1-2) 157-60
9. Hoshimoto K
Changes in biomarkers for endothelial damage and hypercoagulable state
during normal pregnancy.
Dokkyo J Biomed Sci 2001 28 (1) 551-558
（獨協医学会 学術賞 受賞論文）
10. Hoshimoto K, Yamauchi N, Takazawa Y, Onda T, Taketani Y, Fukayama M.
CD44 variant 6 in endometrioid carcinoma of the uterus: its expression
in the adenocarcinoma component is
an independent prognostic marker.
Pathol Res Pract 2003;199(2):71-7
Hayashi M, Hoshimoto K, et al.
Characterization of five marker levels of the hemostatic system and endothelial status
in normotensive pregnancy and pre-eclampsia.
Eur J Haematol. 2002 Nov;69(5-6):297-302.
Hayashi M, Hoshimoto K, et al.
Changes in blood macrophage colony-stimulating factor levels after cesarean section
in normotensive pregnancy and preeclampsia.
Am J Med Sci. 2002 Jul;324(1):5-9.
Hayashi M, Hoshimoto K, et al.
The levels of five markers of hemostasis and endothelial status
at different stages of normotensive pregnancy.
Acta Obstet Gynecol Scand. 2002 Mar;81(3):208-13.
Hayashi M, Hoshimoto K, et al.
Successful pregnancy following gonadotropin therapy in a patient with
hypogonadotropic hypogonadism resulting from craniopharyngioma.
Int J Clin Pract. 2002 Mar;56(2):149-51.
Hayashi M, Hoshimoto K, et al.
Increased levels of macrophage colony-stimulating factor in the placenta and blood in preeclampsia.
Am J Reprod Immunol. 2002 Jan;47(1):19-24.
Hayashi M, Hoshimoto K, et al.
Changes in urinary excretion of six biochemical parameters in normotensive pregnancy and preeclampsia.
Am J Kidney Dis. 2002 Feb;39(2):392-400.
Hayashi M, Hoshimoto K, et al.
Increased excretion of N-acetyl-beta-D-glucosaminidase and beta2-microglobulin in gestational week 30.
Am J Med Sci. 2001 Mar;321(3):168-72.
Hayashi M, Hoshimoto K, et al.
Primary small cell neuroendocrine carcinoma of the vagina. Marked effect of combination chemotherapy: a case report.
Oncology. 2000 May;58(4):300-4. Review.
Hayashi M, Hoshimoto K, et al.
Characterization of five marker levels of the hemostatic system and endothelial status
in normotensive pregnancy and pre-eclampsia.
Eur J Haematol 2002 Nov;69(5-6):297-302
Hayashi M, Hoshimoto K, et al.
Successful conception following Fallopian tube recanalization in infertile patients
with a unilateral proximally occluded tube and a contralateral patent tube.
Hum Reprod 2003 Jan;18(1):96-9
Hayashi M, Hoshimoto K, et al.
Platelet aggregation response and adenosine triphosphate secretion
after abdominal total hysterectomy.
Int J Clin Pract. 2003 Jul-Aug;57(6):461-6.
